Cognition Therapeutics, Inc.

Healthcare

NASDAQ:CGTX · NASDAQ Global Market

Market Cap $104.49M Beta 1.75 P/E (TTM) -6.4

$1.45 -0.70%

-$0.01 today

52W Low $0.25High $3.83

Vol 1.27M · Avg 1.23M

EPS (TTM) -$0.22Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+458.77%

Period High

$3.18

Period Low

$0.26

Latest

$1.45

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Greenwich LifeSciences, Inc.

NASDAQ:GLSI

$345.08M

Opus Genetics, Inc.

NASDAQ:IRD

$336.00M

Surrozen, Inc.

NASDAQ:SRZN

$169.25M

Spero Therapeutics, Inc.

NASDAQ:SPRO

$127.38M

Agenus Inc.

NASDAQ:AGEN

$123.26M

Seer, Inc.

NASDAQ:SEER

$94.29M

Seres Therapeutics, Inc.

NASDAQ:MCRB

$62.75M

Tevogen Bio Holdings Inc.

TVGN

$42.86M

VistaGen Therapeutics, Inc.

VTGN

$22.91M

Atossa Therapeutics, Inc.

ATOS

$17.29M

What is the latest CGTX filing?

The latest filing shown is 8-K dated Jun 18, 2026.

How many recent filings does CGTX have?

Intrinsic Alpha currently shows 20 recent filings for CGTX.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.